294 related articles for article (PubMed ID: 19487373)
1. Metformin in breast cancer: time for action.
Goodwin PJ; Ligibel JA; Stambolic V
J Clin Oncol; 2009 Jul; 27(20):3271-3. PubMed ID: 19487373
[No Abstract] [Full Text] [Related]
2. Metformin as an addition to conventional chemotherapy in breast cancer.
Grenader T; Goldberg A; Shavit L
J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518
[No Abstract] [Full Text] [Related]
3. Metformin, B(12), and enhanced breast cancer response to chemotherapy.
Garcia A; Tisman G
J Clin Oncol; 2010 Jan; 28(2):e19; author reply e20. PubMed ID: 19949002
[No Abstract] [Full Text] [Related]
4. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.
Jiralerspong S; Palla SL; Giordano SH; Meric-Bernstam F; Liedtke C; Barnett CM; Hsu L; Hung MC; Hortobagyi GN; Gonzalez-Angulo AM
J Clin Oncol; 2009 Jul; 27(20):3297-302. PubMed ID: 19487376
[TBL] [Abstract][Full Text] [Related]
5. Is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs.
Yurekli BS; Karaca B; Cetinkalp S; Uslu R
Med Hypotheses; 2009 Oct; 73(4):606-7. PubMed ID: 19560877
[TBL] [Abstract][Full Text] [Related]
6. Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
Stambolic V; Woodgett JR; Fantus IG; Pritchard KI; Goodwin PJ
Breast Cancer Res Treat; 2009 Mar; 114(2):387-9. PubMed ID: 18438706
[No Abstract] [Full Text] [Related]
7. Cracking open window of opportunity trials.
Kalinsky K; Hershman DL
J Clin Oncol; 2012 Jul; 30(21):2573-5. PubMed ID: 22565006
[No Abstract] [Full Text] [Related]
8. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
[TBL] [Abstract][Full Text] [Related]
10. [Results of treatment of adult diabetes mellitus with Metformin-sulfonamide combination (apropos of 197 cases)].
Debry G; Laurent J
J Med Lyon; 1966 Mar; 47(94):407-13. PubMed ID: 5909923
[No Abstract] [Full Text] [Related]
11. Is it time to test metformin in breast cancer prevention trials? A reply to the authors.
Barba M; Muti P
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2565; author reply 2565. PubMed ID: 19745224
[No Abstract] [Full Text] [Related]
12. Metformin: "Old warrior for a new battle".
Jain A
Indian J Cancer; 2010; 47(4):471-2. PubMed ID: 21131766
[No Abstract] [Full Text] [Related]
13. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
Hadad SM; Appleyard V; Thompson AM
Breast Cancer Res Treat; 2009 Mar; 114(2):391. PubMed ID: 18421577
[No Abstract] [Full Text] [Related]
14. Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major.
Dhouib N; Turki Z; Mellouli F; Ouederni M; Yahiaoui S; Nagi S; Ben Slama C; Bejaoui M
Tunis Med; 2010 Feb; 88(2):136. PubMed ID: 20415181
[No Abstract] [Full Text] [Related]
15. A pharmacist's perspective on metformin use and cancer outcomes.
Ceacareanu AC
J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081
[No Abstract] [Full Text] [Related]
16. Emphysematous pyelonephritis in a female with diabetes mellitus, renal calculi, breast cancer and chemotherapy-induced lymphopenia, successfully managed without nephrectomy.
Drositis I; Tsoussis S; Papadakis E; Velegrakis J; Anezinis P
J BUON; 2009; 14(4):725-6. PubMed ID: 20148471
[No Abstract] [Full Text] [Related]
17. Metformin and pancreatic cancer: a clue requiring investigation.
Pollak M
Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
[TBL] [Abstract][Full Text] [Related]
18. [Pancreatic diseases: update 2011].
Ringel J; Lerch MM; Mayerle J
Dtsch Med Wochenschr; 2011 Oct; 136(40):2037-9. PubMed ID: 21960335
[No Abstract] [Full Text] [Related]
19. Measurement of residual disease after neoadjuvant chemotherapy.
Abrial C; Thivat E; Tacca O; Durando X; Mouret-Reynier MA; Gimbergues P; Penault-Llorca F; Chollet P
J Clin Oncol; 2008 Jun; 26(18):3094; author reply 3095. PubMed ID: 18565900
[No Abstract] [Full Text] [Related]
20. [Clinical research on a new hypoglycemic drug combination: glycyclamide and dimethylbiguanide].
Cucurachi P; Dell'Anna A
Clin Ter; 1968 May; 45(4):363-73. PubMed ID: 5738669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
